Skip to main content

Advertisement

Log in

Stress Degradation Studies on Tadalafil and Development of a Validated Stability-Indicating LC Assay for Bulk Drug and Pharmaceutical Dosage Form

  • Limited Short Communication
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A stability-indicating HPLC assay method was developed for the quantitative determination of tadalafil in bulk samples and in pharmaceutical dosage forms in the presence of the degradation products. It involved a 250 mm × 4.6 mm, 5 μm C-18 column. The gradient LC method employs solution A and B as mobile phase. Solution A contains a mixture of buffer (phosphate buffer and tetra-n-butyl ammonium hydrogen sulfate) pH 2.5: acetonitrile (80:20, v/v) and solution B contains a mixture of water: acetonitrile (20:80, v/v). The flow rate was 1.0 mL min−1 and the detection wavelength was 220 nm. The retention time of tadalafil is about 17 min. Tadalafil was subjected to different ICH prescribed stress conditions. Degradation was found to occur in hydrolytic and to some extent in oxidative stress conditions, while the drug was stable to photolytic and thermal stress. The drug was particularly labile under alkaline hydrolytic conditions. The drug was subjected to stress conditions of hydrolysis, oxidation, photolysis and thermal degradation. The assay of stress samples was calculated against a qualified reference standard and the mass balance was close to 99.5%. The developed RP-LC method was validated with respect to linearity, accuracy, precision and ruggedness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. International Conference on Harmonization (2003) Stability testing of new drug substances and products Q1A (R2). International Conference on Harmonization, IFPMA, Geneva

  2. Singh S, Bakshi M (2000) Pharm Tech Online 24:1–14

    Google Scholar 

  3. International Conference on Harmonization (1996) Photo stability testing of new drug substances and productsQ1B. International Conference on Harmonization, IFPMA, Geneva

  4. Bakshi M, Singh S (2002) J Pharm Biomed Anal 28:1011–1040

    Article  CAS  Google Scholar 

  5. Singh S, Singh B, Bahuguna R, Wadhwa L, Saxena R (2006) J Pharm Biomed Anal 41:1037–1040

    Article  CAS  Google Scholar 

  6. Carstensen JT, Rhodes CT (eds) (2000) Drug stability principles and practices, 3rd edn

  7. http://www.cialis.com

  8. Aboul-Enein HY, Ali I (2005) Talanta 65:276

    Article  CAS  Google Scholar 

  9. Shakya AK, Abu-awwad ANA, Arafat TA, Melhim M (2007) J Chromatogr B 852:403–408

    Article  CAS  Google Scholar 

  10. Cheng CL, Chou CH (2005) J Chromatogr B 822:278

    Article  CAS  Google Scholar 

  11. Ali I, Aboul-Enein HY (2004) Chromatographia 60:187–191. doi:10.1365/s10337-004-0366-x

    Article  CAS  Google Scholar 

  12. Rodríguez Flores J, Berzas Nevado JJ, Castaňeda Peňalvo G, Mora Diez N (2004) J Chromatogr B 811:231

    Google Scholar 

  13. Ramakrishna NVS, Vishwottam KN, Puran S, Koteshwara M, Manoj S, Santosh M, Chidambara J, Wishu S, Sumatha B (2004) J Chromatogr B 809:243

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. V. Subba Rao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rao, D.V.S., Radhakrishnanand, P. & Himabindu, V. Stress Degradation Studies on Tadalafil and Development of a Validated Stability-Indicating LC Assay for Bulk Drug and Pharmaceutical Dosage Form. Chroma 67, 183–188 (2008). https://doi.org/10.1365/s10337-007-0478-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-007-0478-1

Keywords